Positioning rituximab in the therapeutic strategies for SLE
Systemic lupus erythematosus (SLE) is one of the most challenging diseases to manage due to its high heterogeneity and unpredictable course. Rituximab is an off-label, widely administered treatment in severe, refractory SLE. Observational and real-world evidence studies have been highly heterogeneou...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2026-07-01
|
| Serie: | Frontiers in Lupus |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/flupu.2026.1877692/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|